|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||
| Receivables | ||||||||||
| Inventory | ||||||||||
| Prepaids and deposits | ||||||||||
| Current portion of other assets | ||||||||||
| Total current assets | ||||||||||
| Other assets | ||||||||||
| Restricted cash and cash equivalents | ||||||||||
| Property, plant and equipment | ||||||||||
| Total non-current assets | ||||||||||
| Total assets | ||||||||||
| Accounts payable | ||||||||||
| Accrued liabilities | ||||||||||
| Current portion of long-term debt | ||||||||||
| Current provision for environmental rehabilitation | ||||||||||
| Current portion of other liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Deferred tax liabilities | ||||||||||
| Long-term debt | ||||||||||
| Provision for environmental rehabilitation | ||||||||||
| Non-current portion of other liabilities | ||||||||||
| Total non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| Share capital | ||||||||||
| Reserves | ||||||||||
| Deficit | ||||||||||
| Total equity | ||||||||||
| ASSETS | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Receivables, net | ||||||||||
| Inventories | ||||||||||
| Prepaids and deposits | ||||||||||
| Other assets | ||||||||||
| Total current assets | ||||||||||
| Non-current assets | ||||||||||
| Other assets | ||||||||||
| Restricted cash | ||||||||||
| Property, plant and equipment, net | ||||||||||
| Total non-current assets | ||||||||||
| Total assets | ||||||||||
| LIABILITIES | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable and accrued liabilities | ||||||||||
| Income taxes payable | ||||||||||
| Debt | ||||||||||
| Reclamation liabilities | ||||||||||
| Other liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Non-current liabilities | ||||||||||
| Deferred tax liabilities | ||||||||||
| Debt | ||||||||||
| Reclamation liabilities | ||||||||||
| Other liabilities | ||||||||||
| Total non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| EQUITY | ||||||||||
| Common shares, unlimited authorized shares with no par value, 867,527,720 and 827,230,192 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total equity | ||||||||||
| Total liabilities and equity | ||||||||||
Loading...